Gufic Biosciences have been granted patent by the Eurasian Patent office (EAPO) for its invention of “A Freeze Dried Parenteral Composition of Tigecycline and Process for Preparation Thereof.”
Tigecycline is a tetracycline antibiotic medication used for a number of bacterial infections and is used to treat certain serious infections including community acquired pneumonia (a lung infection that developed in a person who was not in the hospital), skin infections, and infections of the abdomen.
Further, EAPO member States are Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyzstan, Russian Federation, Tajikistan and Turkmenistan.